comparemela.com
Latest Breaking News On - Druvalumab and bevacizumab plus tace - Page 1 : comparemela.com
Durvalumab and Bevacizumab Plus TACE Improves PFS in Embolization-Eligible, Unresectable HCC
PFS was significantly improved with durvalumab plus bevacizumab and TACE vs TACE alone in patients with unresectable HCC eligible for embolization.
Italy
Japan
Riccardo-lencioni
Department-of-surgery
Critical-area-pathology
Druvalumab-and-bevacizumab-plus-tace
Dotace
Hcc
Hepatocellular-carcinoma
Gastrointestinal-cancer
Gi-cancer
Asco-gi
vimarsana © 2020. All Rights Reserved.